Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4766c842f4e9d2695f49e2f4a8dd021 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71fb6adad6a8fc2f5415c4a7ccca7ec2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b74adca98d67b5e816bb604c9163f2ea http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f449dc7edcb838a32f3ca08feecf42d5 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0008 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 |
filingDate |
2004-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4d91ca50e54d6b37339c04059bacd66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_426ac8d4c3588c082677ce40727cf9fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a436252cbf0ff259acd67f3098a28e2 |
publicationDate |
2005-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2005030249-A1 |
titleOfInvention |
Immunotherapy method |
abstract |
The present invention relates to the use of immunomodifying agents to effect change in the T helper-type 1 (TH1) or T helper-type 2 (TH2) arms of the immune response and thereby treat TH1 or TH2 mediated diseases. In particular, the present invention relates to a method of altering a specific immune response in an individual comprising: i). administering to an individual in need thereof an effective amount of an antigen in immunotherapeutic form, wherein said immune response is down regulated; and ii). subsequently administering to the individual an effective amount of an immunomodifying agent comprising said antigen in immunogenic form. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2548572-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2548572-A4 |
priorityDate |
2003-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |